Kodiak Sciences Inc (KOD)
3.48
-0.12
(-3.33%)
USD |
NASDAQ |
Apr 18, 16:00
3.475
0.00 (0.00%)
After-Hours: 20:00
Kodiak Sciences Free Cash Flow (Quarterly): -59.72M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -59.72M |
| September 30, 2023 | -32.99M |
| June 30, 2023 | -43.43M |
| March 31, 2023 | -59.47M |
| December 31, 2022 | -60.69M |
| September 30, 2022 | -60.36M |
| June 30, 2022 | -71.32M |
| March 31, 2022 | -61.45M |
| December 31, 2021 | -69.89M |
| September 30, 2021 | -83.65M |
| June 30, 2021 | -50.61M |
| March 31, 2021 | -41.41M |
| Date | Value |
|---|---|
| December 31, 2020 | -32.16M |
| September 30, 2020 | -26.18M |
| June 30, 2020 | -13.97M |
| March 31, 2020 | -18.11M |
| December 31, 2019 | -11.45M |
| September 30, 2019 | -7.854M |
| June 30, 2019 | -13.07M |
| March 31, 2019 | -7.214M |
| December 31, 2018 | -8.865M |
| September 30, 2018 | -5.002M |
| June 30, 2018 | -4.486M |
| March 31, 2018 | -11.26M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-83.65M
Minimum
Sep 2021
-7.854M
Maximum
Sep 2019
-43.04M
Average
-43.43M
Median
Jun 2023
Free Cash Flow (Quarterly) Benchmarks
| Avalo Therapeutics Inc | -2.766M |
| Regeneron Pharmaceuticals Inc | 776.20M |
| iBio Inc | -4.706M |
| Puma Biotechnology Inc | 10.41M |
| Dare Bioscience Inc | -8.786M |